Search Results 131-140 of 18155 for CLL

1. Neil E. Kay, M.D. - Doctors and Medical Staff - Mayo Clinic

   MemberCLL Society's Integrative Medicine Award-Selection Committee. 2023 - present. MemberIntegrative Medicine Award Research Review Committee / CLL Society.

2. Financial Difficulty in Patients With Blood Cancer - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250), a physician survey (n=100), and a practice survey completed by each site ...

3. A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.

4. Hematology - Clinical trials

   A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

5. Shanafelt Archives - Mayo Clinic News Network

   ... CLL Patients. ASCO Abstract Number: 6522 An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) ...

6. Clinical trials - Oncology (Medical)

   A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

7. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

8. Hematology - Clinical trials

   Anticipated time on study is up to 5 years. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL) ...

9. A Study to Compare ACP-196 and Obinutuzumab with Chlorambucil, or ACP-19 alone, with Obinutuzumab and Chlorambucil, for Patients with Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

10. Living With Cancer: What do you know about bladder cancer?

    Learn about treatment options, questions to ask your health care provider, strategies for coping and support, and more. Chronic lymphocytic leukemia. Chronic ...